跳至主要内容
临床试验/NCT03036761
NCT03036761已完成不适用

Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines

Hopital Foch4 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年1月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Hopital Foch
入组人数
90
试验地点
4
主要终点
Number of days with migraine and non-migraine headache post inclusion.

研究概览

简要总结

The aim of the study is to show that auriculotherapy decreases the number of days with painful episodes of migraine and headache after 3 months of treatment

详细描述

Prospective, multicenter, controlled and randomized study.

At the inclusion:

  • initial assessment of migraine and headache attacks of the last 3 months with the migraine/headache/treatment diary;
  • quality of life assessment (MIDAS questionnaire).

Patients are randomized in 2 groups (distribution 2/3 AUR+, 1/3 AUR-):

  • AUR+: experimental group "Auriculotherapy". Patients benefit from 3 sessions of auriculotherapy at one month intervals.
  • AUR-: control group. Patients do not benefit from auriculotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Months 至 80 Years(Child, Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Aged from 18 to 80;
  • •Benefiting from social security scheme or legal successor;
  • •Having given their non-opposition to the study; ·
  • •Diagnosis of chronical migraine for more than 6 months;
  • •Without background treatment or with stable background therapy for more than 1 month;
  • •Presenting a calendar of migraines and headaches mentioning the number of days with pain, intensity of pain and treatments for at least 3 months.
  • •Non inclusion Criteria:
  • •Patient with less than 6 painful episodes in 3 months;
  • •History or actual mental health disorder;
  • •Dependence on opioids or tranquillizers;
  • •Secondary headaches;
  • •Incapacitated to keep a diary of the migraines / headaches / treatments;
  • •Contraindications for the use of auriculotherapy (scheduled Magnetic resonance imaging examination, declared pregnancy, breastfeeding, artificial heart valves, Haemophilia, effective anticoagulation treatment);
  • •Having received auriculotherapy treatment in the indication of the study in the last 12 months before inclusion;
  • •Scheduled to start a new drug or non-drug therapy which could interfere with the study (antidepressant, opioids, anticonvulsant psychological therapy, physiotherapy, deep brain stimulation, etc..);
  • •Modification of background treatment during the month before inclusion.

排除标准

  • •Allergy or infection of the auricle
  • •Pregnancy

研究组 & 干预措施

AUR+: Auriculotherapy

Experimental

Patients benefit from 3 sessions of auriculotherapy at one month intervals.

干预措施: Auriculotherapy (Procedure)

AUR-: No auriculotherapy

No Intervention

Patients do not benefit from auriculotherapy.

结局指标

主要结局

Number of days with migraine and non-migraine headache post inclusion.

时间窗: 3 months

Evaluated with the patient's migraine/headache/treatment diary of the last 3 months after inclusion. One day with painful episodes of migraines and non-migraines headaches is a day when: * the pain episode lasts more than 4 hours, * or the pain episode is suppressed by a specific treatment known to the patient.

次要结局

  • Intensity of pain episodes (migraines and non-migraine headaches) post inclusion: numerical scale(3 months)
  • Evaluation of the quality of life of the patient: MIDAS score(3 months)
  • Tolerance of auriculotherapy treatment(3 months)
  • Number of days with migraine post inclusion.(3 months)
  • Number of days with non migraine headache post inclusion.(3 months)
  • Evolution of antalgic use (triptan and non-triptan) in migraine patients.(3 months)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Interest of Auriculotherapy in Prophylaxis of... | 临床试验